Average Distribution: 49.17% (+9.51% 1wk)
- 55 Groups (27.5%) are in the Stage 4 zone
- 95 Groups (47.5%) are in the Stage 1 or Stage 3 zone
- 50 Groups (25%) are in the Stage 2 zone
The IBD Industry Groups Bell Curve moved strongly higher this week with a +9.51% gain to close the week at 49.17%.
The amount of groups in Stage 4 decreased by -48 (-24%), and the amount of groups in Stage 2 increased by +28 (+14%), while the amount groups in Stage 1 or Stage 3 decreased by -20 (-10%).
The overall distribution of the bell curve is now almost in the middle of the range, which is firmly in Stage 1 territory, after coming from the lower Stage 4 zone. So its position has strengthened, with less groups in Stage 4 declines, and more groups moving into Stage 2 advances. But as a whole it still remains very neutral, at just under 50%. Hence to improve to an overall Stage 2 position (bull market) it needs to improve by more than +11% still, and then start closing regularly above the 60% level. But a move to Stage 2 isn't guaranteed, as Stage 1 can also return to Stage 4. So we still need to stay alert for any signs of weakness. i.e. lots of failed Stage 2 breakout attempts would be a major red flag if that happens in the coming weeks, as earnings season picks up speed, as there has been numerous Stage 2 breakouts this week and over the past month. So how they behave could give key insight to the overall market condition.
To compare against last weeks chart go to: IBD Industry Groups Bell Curve – Bullish Percent (6 January 2023).
Below is the data tables of the 200 IBD groups bullish percent in order of relative strength and the position changes over the last 1, 2 and 4 weeks (Members Only).
Become a Stage Analysis Member:
To see more like this and other premium content, such as the regular US Stocks watchlist, detailed videos and intraday posts, become a Stage Analysis member.
Disclaimer: For educational purpose only. Not investment advice. Seek professional advice from a financial advisor before making any investing decisions.